Investigating the Influence of Apelin and Ghrelin in Multiple Sclerosis: A Study of Patients Undergoing Immunomodulatory Treatment - Top-Institutions - MDSpire

Investigating the Influence of Apelin and Ghrelin in Multiple Sclerosis: A Study of Patients Undergoing Immunomodulatory Treatment

  • By

  • Bożena Adamczyk

  • Natalia Morawiec

  • Michał Rakoca

  • Agata Sowa

  • Ksawier Sawa

  • Monika Adamczyk-Sowa

  • April 28, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Multiple Sclerosis

  • #2

    Brigham and Women's Hospital - Partners MS Center
    Brigham and Women's Hospital - Partners MS Center

    Boston, MA

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology

  • #3

    University of California, San Francisco (UCSF) Multiple Sclerosis Center
    University of California, San Francisco (UCSF) Multiple Sclerosis Center

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology

  • #4

    Karolinska Institutet - Neuroimmunology and Multiple Sclerosis Research
    Karolinska Institutet - Neuroimmunology and Multiple Sclerosis Research

    Stockholm, Sweden

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Multiple Sclerosis

  • #5

    Johns Hopkins Multiple Sclerosis Center
    Johns Hopkins Multiple Sclerosis Center

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology

Original Source(s)

Investigating the Influence of Apelin and Ghrelin in Multiple Sclerosis: A Study of Patients Undergoing Immunomodulatory Treatment

  • by Bożena Adamczyk, Natalia Morawiec, Michał Rakoca, Agata Sowa, Ksawier Sawa, Monika Adamczyk-Sowa

  • April 28, 2026

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Editorial: Diffusion-weighted imaging: advances and implementations in neurology

Long-Term Outcomes of Ublituximab Treatment in Multiple Sclerosis: Findings from the ULTIMATE I and II Open-Label Extension Trials